Young women with small, low-grade breast tumors may safely skip axillary lymph node surgery.
Analysis of 4,400+ breast cancer patients found women under 50 with grade 1 tumors ≤1 cm and no LVI had just 4.92% lymph node metastasis rate—nearly identical to the 5.95% in women ≥50 with the same features. Age alone does not determine nodal risk in low-risk breast cancer.
Young women with small, low-grade breast tumors may safely skip axillary lymph node surgery.
Analysis of 4,400+ breast cancer patients found women under 50 with grade 1 tumors ≤1 cm and no LVI had just 4.92% lymph node metastasis rate—nearly identical to the 5.95% in women ≥50 with the same features. Age alone does not determine nodal risk in low-risk breast cancer.
Key Findings
- Women with grade 1, ≤1 cm, no-LVI tumors had <6% nodal metastasis regardless of age
- Rate in women <50: 4.92% vs. 5.95% in women ≥50
- Age alone is not a reliable predictor of nodal involvement
- Authors propose younger women should be eligible for axillary de-escalation trials
Implications
De-escalation of axillary surgery should be based on pathological criteria, not age. Prospective trials warranted.
Caveats
Single-institution retrospective; abstract-only. Small subgroup sizes for younger patients. Requires prospective validation.
Source: The breast journal — 2026-01-01
